Email ID
Password
Sign me in automatically next time
ImmusanT start-up raises $20m to advance therapeutic vaccine for coeliac disease

ImmusanT, a US biotech which was launched in March 2011 from research which originated in Australia, has raised $20 million in a series A round of financing from Vatera Healthcare Partners...
15 December 2011
Nancy Faigen

nancy.faigen@informausa.com





Please Login to read the full article.
EVENTS
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36